| Issue |
Section |
Title |
File |
| Vol 27, No 4 (2020) |
Articles |
Modern topical treatment of psoriasis in diabetic patients |
|
| Vol 27, No 8 (2020) |
Articles |
Clinical and microbiological features of atopic dermatitis in HIV-positive patients (literature review) |
|
| Vol 27, No 8 (2020) |
Articles |
Clinical case of mycosis fungoides |
|
| Vol 27, No 12 (2020) |
Articles |
Clinical features of skin lesions in patients with diabetes mellitus |
|
| Vol 27, No 14 (2020) |
Articles |
Treatment of psoriatic erythroderma with biological drugs |
|
| Vol 27, No 14 (2020) |
Articles |
Influence of inflammatory dermatoses on the quality of life of HIV-positive patients |
|
| Vol 28, No 4 (2021) |
Articles |
Optimization of the diabetes screening questionnaire for patients with psoriasis |
|
| Vol 28, No 8 (2021) |
Articles |
Analysis of comorbid conditions and tolerability of treatment with genetically engineered biological drugs and methotrexate in patients with psoriasis |
|
| Vol 28, No 8 (2021) |
Articles |
Modern therapy of psoriasis from the point of view of systemic inflammation: experience of using the drug Efleira |
|
| Vol 28, No 8 (2021) |
Articles |
Experience with dupilumab in patients with atopic dermatitis |
|
| Vol 28, No 8 (2021) |
Articles |
Epi-Oral F199 - systemic anti-age therapy and antioxidant protection: ingredients |
|
| Vol 28, No 8 (2021) |
Articles |
Longitudinal systemic therapy of plaque psoriasis: a literature review with a case report of use of ixekizumab |
|
| Vol 28, No 8 (2021) |
Articles |
Type 1 neurofibromatosis in Western Siberia, prevalence, features of clinical manifestations |
|
| Vol 28, No 8 (2021) |
Articles |
Urine chromatography in skin diseases |
|
| Vol 28, No 8 (2021) |
Articles |
Review of clinical trials of the IL-23 inhibitor guselkumab. Experience of using genetically engineered biological therapy with guselkumab in a patient with severe arthropathic psoriasis |
|
| Vol 28, No 8 (2021) |
Articles |
Injection bioreparation is a promising direction in the treatment of involutional skin changes |
|
| Vol 28, No 8 (2021) |
Articles |
A universal injectable preparation for the correction of cosmetological and dermatological skin problems |
|
| Vol 28, No 8 (2021) |
Articles |
An innovative injection method for correcting excess adipose tissue in the face, submental area and neck |
|
| Vol 28, No 10 (2021) |
Articles |
Possibilities of using anti-cytokine drugs for inflammatory dermatoses in HIV-positive patients |
|
| Vol 29, No 8 (2022) |
Articles |
Experience with the use of netakimab for the treatment of psoriasis in HIV-infected patients |
|
| Vol 29, No 8 (2022) |
Articles |
Tuberous sclerosis: features of the clinical course and prevalence in Western Siberia |
|
| Vol 29, No 10 (2022) |
Articles |
Experience with the use of baricitinib in the treatment of atopic dermatitis in HIV-infected patients |
|
| Vol 29, No 10 (2022) |
Articles |
The role of systemic inflammation in HIV-infected patients with moderate and severe psoriasis |
|
| Vol 29, No 13 (2022) |
Articles |
Modern possibilities for correcting the uric acid level and eliminating skin manifestations of gout |
|
